Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rejoice Agyeiwaa Arthur"'
Autor:
Wellington Owusu, Arnoud H. M. van Vliet, Natalie E. Riddell, Graham Stewart, Winifred C. Akwani, Sherihane Aryeetey, Rejoice Agyeiwaa Arthur, Augustina Angelina Sylverken, Suzanne M. Hingley-Wilson
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
In low-resource settings with high tuberculosis (TB) burdens, lack of rapid diagnostic methods for detection and differentiation of Mycobacterium tuberculosis complex (MTBC) is a major challenge affecting TB management. This study utilized comparativ
Externí odkaz:
https://doaj.org/article/d48580be4557464aa03421d6e43ebd92
Autor:
Augustina Angelina Sylverken, Alexander Kwarteng, Sampson Twumasi-Ankrah, Michael Owusu, Rejoice Agyeiwaa Arthur, Rexford Mawunyo Dumevi, Louis Adu-Amoah, Nicholas Addofoh, Portia Boakye Okyere, Francisca Dzata, Frank Bonsu, Yaw Adusi-Poku, Katharina Kranzer, Andrew Siroka, Wayne van Gemert, Anna Dean, Ellis Owusu-Dabo
Publikováno v:
PLoS ONE, Vol 16, Iss 6 (2021)
Resistance to Tuberculosis drugs has become a major threat to the control of tuberculosis (TB) globally. We conducted the first nation-wide drug resistance survey to investigate the level and pattern of resistance to first-line TB drugs among newly a
Externí odkaz:
https://doaj.org/article/80f08535243d43aabea5e4ad2a7f076d
Autor:
Portia Boakye Okyere, Alexander Kwarteng, Frank Bonsu, Ellis Owusu-Dabo, Anna S. Dean, Wayne van Gemert, Rexford Mawunyo Dumevi, Yaw Adusi-Poku, Louis Adu-Amoah, Sampson Twumasi-Ankrah, Nicholas Addofoh, Francisca Dzata, Michael Owusu, Katharina Kranzer, Rejoice Agyeiwaa Arthur, Andrew M. Siroka, Augustina Sylverken
Publikováno v:
PLoS ONE, Vol 16, Iss 6 (2021)
PLoS ONE, Vol 16, Iss 6, p e0252819 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 6, p e0252819 (2021)
PLoS ONE
Resistance to Tuberculosis drugs has become a major threat to the control of tuberculosis (TB) globally. We conducted the first nation-wide drug resistance survey to investigate the level and pattern of resistance to first-line TB drugs among newly a